Apremilast and psoriasis in the real world: A retrospective case series - 19/06/20
Funding sources: None. |
|
Disclosure: Dr Kerdel has served as a speaker for Amgen, AbbVie, Janssen, Lilly, Celgene, Actelion, Novartis, Regeneron, Sanofi, Valeant, and Ortho. He has received research support from Amgen, AbbVie, Janssen, Lilly, Celgene, Actelion, Novartis, Pfizer, Leo Pharma, Regeneron, Sanofi, UCB, AstroZeneca, XBiotech, Dr. Reddy's Laboratories, Ortho, and Menlo. He has served on the board of directors of Celgene and Lilly. Drs Dozier and Bartos have no conflicts of interest to declare. |
|
Reprints not available from the authors. |
Vol 83 - N° 1
P. 221-222 - juillet 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?